Assembly Biosciences Inc
Assembly Biosciences Inc (ASMB) Straddle
ASMB straddle scan found 14 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 50.5%.
Read more
Trading a ASMB straddle lets you take a pure volatility position on Assembly Biosciences Inc without committing to a direction. Assembly Biosciences Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ASMB straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ASMB profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Assembly Biosciences Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ASMB straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc.
to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ASMB straddle is the cleanest expression of that view. Our scanner prices every ASMB straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ASMB straddle into a catalyst or short a ASMB straddle to harvest decay, the options straddle setups that matter are all in one place.
| Mar 19, 2027 | 50.00 | $27.60 | 179 | 16% | 50.5% | $77.60 | $22.40 | 0 |
| Mar 19, 2027 | 30.00 | $11.25 | 179 | 16% | 49.1% | $41.25 | $18.75 | 1 |
| Mar 19, 2027 | 35.00 | $14.70 | 179 | 16% | 48.9% | $49.70 | $20.30 | 28 |
| Nov 20, 2026 | 25.00 | $5.25 | 60 | 16% | 48.7% | $30.25 | $19.75 | 0 |
| Oct 16, 2026 | 30.00 | $5.68 | 25 | 16% | 48.0% | $35.68 | $24.33 | 12 |
| Dec 18, 2026 | 45.00 | $22.18 | 88 | 16% | 45.0% | $67.18 | $22.83 | 0 |
| Mar 19, 2027 | 25.00 | $9.75 | 179 | 16% | 43.7% | $34.75 | $15.25 | 8 |
| Oct 16, 2026 | 25.00 | $3.90 | 25 | 16% | 42.8% | $28.90 | $21.10 | 0 |
| Nov 20, 2026 | 30.00 | $8.25 | 60 | 16% | 42.4% | $38.25 | $21.75 | 0 |
| Dec 18, 2026 | 30.00 | $9.80 | 88 | 16% | 40.9% | $39.80 | $20.20 | 3 |
As of September 21, 2026
Find the right straddle before volatility moves
Track ASMB straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→